Robotic pill company Rani Therapeutics (Nasdaq:RANI) has begun developing RT-111, a RaniPill GO capsule containing a biosimilar of Johnson & Johnson’s (NYSE:JNJ) Stelara (ustekinumab). The company anticipates that RT-111 could potentially treat psoriatic arthritis, ulcerative colitis, Crohn’s disease and psoriasis. The FDA first approved Stelara in 2009 for psoriasis. Stelara is available in intravenous and…
Fast Company 2022 World-Changing Ideas Awards highlight multiple pharma innovations
The pharmaceutical industry had an excellent showing in the Fast Company 2022 World-Changing Ideas Awards series, focusing on organizations dedicated to ‘social good.’ This year, the publication awarded three drug-delivery applications with awards, and Siemens took home a prize for its work in accelerating COVID-19 vaccine development. A 3D printed vaccine patch could deliver vaccine doses…